EGFR and cancer: A photo-activatable ternary complex consisting of multifunctional shielding material (MSM) with photosensitizer (PS)-conjugated chondroitin sulfate (CS) and PEI-based binary complexes containing EGFR-plasmid vector based-small hairpin RNAs (shRNAs) for CD44 targeted cancer therapy was developed.